Healthpeak Properties (NYSE:DOC) Updates FY 2025 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 1.810-1.870 for the period, compared to the consensus EPS estimate of 1.860. The company issued revenue guidance of -.

Healthpeak Properties Trading Down 1.2 %

Shares of NYSE:DOC traded down $0.25 during midday trading on Monday, reaching $20.41. The company’s stock had a trading volume of 5,578,983 shares, compared to its average volume of 4,370,339. The firm has a market cap of $14.27 billion, a price-to-earnings ratio of 43.42, a price-to-earnings-growth ratio of 2.22 and a beta of 1.15. The business has a 50 day moving average price of $20.75 and a 200 day moving average price of $21.55. Healthpeak Properties has a 1 year low of $16.01 and a 1 year high of $23.26. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be issued a $0.305 dividend. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 5.98%. Healthpeak Properties’s payout ratio is 255.32%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DOC shares. Mizuho decreased their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and increased their target price for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Finally, Royal Bank of Canada boosted their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus price target of $24.15.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.